Literatura académica sobre el tema "Dyscrasite"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Dyscrasite".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Dyscrasite"
Osadchii, E., D. Boström, S. Lunin y E. Rosén. "Thermodynamic properties of dyscrasite (Ag 3 Sb) at isostatic pressures 4000-8000 bar". Physics and Chemistry of Minerals 25, n.º 4 (19 de marzo de 1998): 288–91. http://dx.doi.org/10.1007/s002690050116.
Texto completoKalinin, Arkadii A., Yevgeny E. Savchenko y Ekaterina A. Selivanova. "Mustard Gold in the Oleninskoe Gold Deposit, Kolmozero–Voronya Greenstone Belt, Kola Peninsula, Russia". Minerals 9, n.º 12 (13 de diciembre de 2019): 786. http://dx.doi.org/10.3390/min9120786.
Texto completoZachariáš, Jiří y Matěj Němec. "Gold to aurostibite transformation and formation of Au-Ag-Sb phases: the Krásná Hora deposit, Czech Republic". Mineralogical Magazine 81, n.º 4 (agosto de 2017): 987–99. http://dx.doi.org/10.1180/minmag.2016.080.145.
Texto completoHartshorn, Edward A., Gary M. Levin y C. Lindsay DeVane. "A Review of Cyclic Antidepressant-Induced Blood Dyscrasias". Annals of Pharmacotherapy 26, n.º 3 (marzo de 1992): 378–83. http://dx.doi.org/10.1177/106002809202600313.
Texto completoLatif, Zahid, Faraz Jabbar y Brendan D. Kelly. "Clozapine and blood dyscrasia". Psychiatrist 35, n.º 1 (enero de 2011): 27–29. http://dx.doi.org/10.1192/pb.bp.109.026054.
Texto completoSutherland, Rory A. y Richard I. Crawford. "Scalp biopsy identifies systemic amyloidosis presenting as isolated telogen effluvium: A case report". SAGE Open Medical Case Reports 7 (enero de 2019): 2050313X1984778. http://dx.doi.org/10.1177/2050313x19847783.
Texto completoDunk, Louisa R., Linda J. Annan y Christopher D. Andrews. "Rechallenge with clozapine following leucopenia or neutropenia during previous therapy". British Journal of Psychiatry 188, n.º 3 (marzo de 2006): 255–63. http://dx.doi.org/10.1192/bjp.188.3.255.
Texto completoHarris, Donald C., Andrew C. Roberts, J. H. Gilles Laflamme y Chris J. Stanley. "Criddleite, TlAg2Au3Sb10S10, a New Gold-Bearing Mineral from Hemlo, Ontario, Canada". Mineralogical Magazine 52, n.º 368 (diciembre de 1988): 691–97. http://dx.doi.org/10.1180/minmag.1988.052.368.13.
Texto completoMunshi, Tariq, Farooq Naeem, Mohammed Ayub, Saeed Farooq, Davit Khachatryan, Selim Asmer, Peter Wang et al. "The haematological side effects of clozapine: literature review and meta-analysis". BJPsych Open 7, S1 (junio de 2021): S274. http://dx.doi.org/10.1192/bjo.2021.729.
Texto completoMichaeli, J., R. Niesvizky, D. Siegel, M. Ladanyi, PH Lieberman y DA Filippa. "Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorder". Blood 86, n.º 3 (1 de agosto de 1995): 1159–62. http://dx.doi.org/10.1182/blood.v86.3.1159.1159.
Texto completoTesis sobre el tema "Dyscrasite"
Ali, H. S. "Drug induced blood dyscrasias : Aminoglutethimide and related compounds". Thesis, Cardiff University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.377874.
Texto completoLimpas, Yvon. "Le POEMS syndrome : entité particulière au sein des dyscrasies plasmocytaires". Bordeaux 2, 1989. http://www.theses.fr/1989BOR25325.
Texto completoPaletta, Dominique Raoux. "Syndrome de Crow-Fukase : à propos d'une observation et revue de la littérature". Montpellier 1, 1988. http://www.theses.fr/1988MON11235.
Texto completoSoubrier, Martin. "Le Syndrome POEMS". Clermont-Ferrand 1, 2003. http://www.theses.fr/2003CLF1MM11.
Texto completoGutknecht-Dignat, Sandrine. "Le syndrome d'hyperperméabilité capillaire idiopathique : à propos d'un cas". Montpellier 1, 1998. http://www.theses.fr/1998MON11040.
Texto completoCARLISI, Melania. "EVALUATION AND POTENTIAL ROLE OF BONE MARROW TISSUE-RESIDENT MEMORY T-CELLS IN PATIENTS WITH PLASMA CELL DYSCRASIAS". Doctoral thesis, Università degli Studi di Palermo, 2020. http://hdl.handle.net/10447/400371.
Texto completoMILANI, PAOLO. "The use of mass spectrometry for the diagnosis of plasma cell dyscrasias: focus on light chain (AL) amyloidosis patterns". Doctoral thesis, Università degli studi di Pavia, 2019. http://hdl.handle.net/11571/1285988.
Texto completoKiran, Aramanda Shanmukha. "Exotic eutectic microstructures". Thesis, 2021. https://etd.iisc.ac.in/handle/2005/5476.
Texto completoHavyarimana, Sandra. "Evaluation of prognostic markers in plasma cell dyscrasias". Thesis, 2017. https://hdl.handle.net/10539/24917.
Texto completoIntroduction: Plasma cell dyscrasias (PCDs) are a heterogeneous group of diseases in which there is expansion of clonal plasma cells which may produce monoclonal immunoglobulins. CD200 is a membrane glycoprotein of the type I immunoglobulin superfamily transmembrane glycoprotein. It is postulated that CD200 is expressed by the plasma cells in a significant number of cases of multiple myeloma (MM), but normal plasma cells do not express it. It may thus assist in confirming clonality of plasma cells in PCDs. Aims: To evaluate CD200 expression as a potential diagnostic and prognostic marker in plasma cell dyscrasias and to compare the results with other known prognostic factors. Methods: CD200 expression was evaluated by immunophenotypic analysis on normal, reactive and clonal plasma cells and expressed as a mean fluorescent intensity (MFI) value. Cut-off for positive CD200 was established. A negative population was established using different methodologies to exclude reactive plasma cells. CD200 was then compared with diagnostic and prognostic markers currently in use in our laboratory. Results: An MFI of ≥ 30 was the cut-off for CD200 positivity. CD200 was expressed by 76.5% of PCDs cases. CD200 did not predict anaemia, hypercalcaemia or renal dysfuction which are biochemical criteria for the diagnosis of multiple myeloma. CD200 expression did not correlate with traditional prognostic markers such as beta 2 microglobulin (β2M), lactate dehydrogenase (LDH) or genetic abnormalities (by fluorescence in situ hybridization analysis). Cases with plasma cell CD200 expression had a higher monoclonal band level compared to those without CD200 expression. Conclusion: CD200 is a useful tool to evaluate plasma cell clonality; however in our settings where there is a high prevalence of infectious diseases, particularly HIV infection, CD200 might yield false positive results most likely because of small oligoclones of reactive plasma cells. CD200 as a prognostic tool in PCDs could not be confirmed in this small study.
LG2018
Phipps, Jonathan E. "Toward Personalized Medicine: The potential role of RNA interference in Plasma Cell Dyscrasia". 2011. http://trace.tennessee.edu/utk_graddiss/1217.
Texto completoLibros sobre el tema "Dyscrasite"
Roccaro, Aldo M. y Irene M. Ghobrial, eds. Plasma Cell Dyscrasias. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5.
Texto completoKelly, John J., Robert A. Kyle y Norman Latov. Polyneuropathies Associated with Plasma Cell Dyscrasias. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2065-4.
Texto completoMinetti, Luigi, Giuseppe D’Amico y Claudio Ponticelli, eds. The Kidney in Plasma Cell Dyscrasias. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1315-8.
Texto completo1928-, Kyle Robert A. y Latov Norman, eds. Polyneuropathies associated with plasma cell dyscrasias. Boston: Nijhoff, 1987.
Buscar texto completoL, Minetti, D'Amico G. 1929- y Ponticelli C, eds. The Kidney in plasma cell dyscrasias. Dordrecht: Kluwer Academic Publishers, 1988.
Buscar texto completoZimmerman, Todd M. y Shaji K. Kumar, eds. Biology and Management of Unusual Plasma Cell Dyscrasias. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4419-6848-7.
Texto completoW, Pruzanski y Keystone E. C, eds. Paraproteins in disease: Investigation of plasma cell dyscrasia. Edinburgh: Churchill Livingstone, 1985.
Buscar texto completoW, Pruzanski y Keystone E. C, eds. Paraproteins in desease: Investigation of plasma cell dyscrasia. Edinburgh: Churchill Livingstone, 1985.
Buscar texto completoGhobrial, Irene M. y Aldo M. Roccaro. Plasma Cell Dyscrasias. Springer, 2018.
Buscar texto completoPlasma Cell Dyscrasias. Springer, 2016.
Buscar texto completoCapítulos de libros sobre el tema "Dyscrasite"
Castroviejo, Ricardo. "Dyscrasite (dy, dyscrasite, stibiotriargentite)". En A Practical Guide to Ore Microscopy—Volume 1, 265–68. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-12654-3_44.
Texto completoSpeer, Tod W., Christin A. Knowlton, Michelle Kolton Mackay, Charlie Ma, Lu Wang, Larry C. Daugherty, Brandon J. Fisher et al. "Dyscrasias". En Encyclopedia of Radiation Oncology, 168. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_596.
Texto completoMateos, María-Victoria y Ola Landgren. "MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology". En Plasma Cell Dyscrasias, 3–12. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_1.
Texto completoNeri, Paola, Nizar J. Bahlis, Claudia Paba-Prada y Paul Richardson. "Treatment of Relapsed/Refractory Multiple Myeloma". En Plasma Cell Dyscrasias, 169–94. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_10.
Texto completoLonial, Sagar. "Treatment of MM: Upcoming Novel Therapies". En Plasma Cell Dyscrasias, 195–205. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_11.
Texto completoLee, Susan J. y Ivan Borrello. "Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma". En Plasma Cell Dyscrasias, 207–25. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_12.
Texto completoJethava, Yogesh S. y Frits van Rhee. "Transplantation for Multiple Myeloma". En Plasma Cell Dyscrasias, 227–50. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_13.
Texto completoEda, Homare, Loredana Santo, G. David Roodman y Noopur Raje. "Bone Disease in Multiple Myeloma". En Plasma Cell Dyscrasias, 251–70. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_14.
Texto completoDispenzieri, Angela y Giampaolo Merlini. "Immunoglobulin Light Chain Systemic Amyloidosis". En Plasma Cell Dyscrasias, 273–318. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_15.
Texto completoKapoor, Prashant, Stephen M. Ansell y Esteban Braggio. "Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment". En Plasma Cell Dyscrasias, 321–61. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_16.
Texto completo